AV7-18570-18003

3 vaccinations 6 coded responses 26 check-ins 6 free-text entries 3 call cases

Sex: Female
Age at first dose: 41-45
ZIP prefix: 945 / CA
Registered: 2021-02-11

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Registered dependents

FAU-26792-40131 Child or adolescent in my care · Male · 2022-06-26

Possible VAERS report

VAERS ID	Confidence	Score	Runner-up	Shared symptoms	Dose	State	VAERS vaccinated / onset / received	Call case
2526773 (opens in a new window)	high	9 / 11	3	3 of 13 VAERS symptoms	same dose (3)	CA matches	2021-12-07 / 2022-01-06 / 2022-12-08 received the same day as the last call	case 1208528

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-11
Registered in v-safe
2021-02-11
Dose 1 — Pfizer-BioNTech
2021-02-11
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2021-02-12
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Joint pains, Muscle or body aches

Adult check-in
2021-02-13
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-02-14
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-15
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-16
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Muscle or body aches

Adult check-in
2021-02-17
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-20
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-02-25
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-03-04
Dose 2 — Pfizer-BioNTech
2021-03-04
Health check-in — day 0, dose 2
Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-03-06
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-03-07
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-03-08
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-03-09
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-03-10
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-11
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-03-20
Survey response — day 14, dose 2
MedDRA: Dizziness, Migraine, Pre-existing disease — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities

Free text: Dizziness, migraine headache. Pre-existing conditions but worsening

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-25
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-04-01
Survey response — day 28, dose 2
MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activities

Free text: More frequent headaches

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-08
Survey response — day 35, dose 2
MedDRA: Muscular weakness — Feeling: Good · Be unable to do your normal daily activities

Free text: Episode of generalized muscle weakness lasting 4 hours. Has happened before in the past but do not have diagnosis and had not occurred for several months

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-15
Survey response — day 42, dose 2
MedDRA: Asthenia, Myalgia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Ongoing Muscle pain with recurrent episodes of weakness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-15
Report sent to call center — day 42, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-03
Survey response — 3 months, dose 2
MedDRA: Condition aggravated, Muscular weakness, Pre-existing disease — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization

Free text: Repeated attacks of severe muscle weakness, sudden worsening of pre-existing POTS

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-03
Report sent to call center — 3 months, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-09-02
Health check-in — 6 months, dose 2
Feeling: Fair

Adult check-in
2021-11-18
Call 1 — Left Voicemail
2021-12-07
Dose 3 — Pfizer-BioNTech
2022-03-04
Health check-in — 12 months, dose 2
Feeling: Fair

Adult check-in
2022-06-07
Health check-in — 6 months, dose 3
Feeling: Fair

Adult check-in
2022-12-07
Survey response — 12 months, dose 3
MedDRA: Hemiparesis, Seizure — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization

Free text: Hemiparesis, possible CVA, non-epileptic seizures

MedDRA releases: 2024-11 · check-in free text available
2022-12-07
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-12-08
Call successful
Does not wish to fill out VAERS report
2022-12-08
Call successful
Does not wish to fill out VAERS report
2022-12-08
Call successful
Completed over the phone

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-11	Pfizer-BioNTech
2	2021-03-04	Pfizer-BioNTech
3	2021-12-07	Pfizer-BioNTech	No

Call center

3 call center cases

3 successful

VAERS report filed, before or during a call: 1

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 6 — day 14, dose 2

2021-03-20

Symptoms: Dizziness, migraine headache. Pre-existing conditions but worsening

Release 6 — day 28, dose 2

2021-04-01

Symptoms: More frequent headaches

Release 7 — day 35, dose 2

2021-04-08

Symptoms: Episode of generalized muscle weakness lasting 4 hours. Has happened before in the past but do not have diagnosis and had not occurred for several months

Release 7 — day 42, dose 2

2021-04-15

Symptoms: Ongoing Muscle pain with recurrent episodes of weakness

Release 8 — 3 months, dose 2

2021-06-03

Symptoms: Repeated attacks of severe muscle weakness, sudden worsening of pre-existing POTS

Release 12 — 12 months, dose 3

2022-12-07

Symptoms: Hemiparesis, possible CVA, non-epileptic seizures

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Asthenia	✓	✓	✓
SD	Condition aggravated	✓	✓	✓
SD	Dizziness	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Hemiparesis	·	·	✓
SD	Migraine	✓	✓	✓
SD	Muscular weakness	✓	✓	✓
SD	Myalgia	✓	✓	✓
SD	Pre-existing disease	✓	✓	✓
SD	Seizure	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release